Institution record
Inter
Inter Pan Pasifik Futures, PT
- Source score
- —
- Warnings
- 0
- Comments
- 0
Licence records
Licences within our coverage (firms authorised in the uk, ireland and gibraltar) are listed first. Check each one on the regulator's own register.
| Regulator | Licence no. | Status | Licensed entity | Date | |
|---|---|---|---|---|---|
ICDXTier-2 Indonesia Commodity & Derivatives Exchange | 042/SPKB/ICDX/Dir/IX/2010 | No licence | Inter Pan Pasifik Futures, PT | — |
Peer regulatory & risk comparison
Side-by-side supervisory and risk benchmark comparing Inter against peer institutions in our firms authorised in the uk, ireland and gibraltar dataset.
| Institution | Primary regulators | Regulated / total | Risk classification | Source score | Warnings |
|---|---|---|---|---|---|
| Inter (this record) | ICDX | 0 / 1 | Risk level not supplied | — | 0 |
| Coinbase | CBIFCACBI+6 | 9 / 9 | Risk level not supplied | — | 1 |
| Kraken | CBICBIFCA+2 | 5 / 5 | Risk level not supplied | — | 0 |
| eToro | FCAGFSCFSA+5 | 6 / 8 | Risk level not supplied | — | 0 |
| MUFG Bank | PRAFCAOCC+4 | 7 / 7 | Risk level not supplied | — | 0 |
| CMCMarkets | FCAFCAFMA+3 | 5 / 6 | Risk level not supplied | — | 0 |
Inter: institutional due diligence FAQ
Key supervisory, licensing, and counterparty verification questions generated from the dataset.
What is Inter's regulatory licence status and supervisory authorisation?
In our imported dataset, Inter (legal entity reference: Inter Pan Pasifik Futures, PT) holds 1 recorded licence entry, of which 0 carry a "regulated" status and 0 are marked regulated or registered: ICDX (Indonesia Commodity & Derivatives Exchange) — licence 042/SPKB/ICDX/Dir/IX/2010, status: no licence, Tier-2. Institutional due diligence requires verifying that the exact legal entity on your counterparty agreement matches the licensed entity name and registration number on the official ICDX public register.
Which of Inter's jurisdictions and licences fall within this site's regulatory coverage?
Inter is registered at Multivision Tower Lantai 20, Jl. Kuningan Mulia Lot 9B, Kuningan Persada Complex, Jakarta Selatan 12980 and tracked under our firms authorised in the uk, ireland and gibraltar scope based on its institutional service profile (CFDs, Precious metals, Stock indices, Forex) rather than a domestic focus licence. Its 1 recorded licence (ICDX) should be evaluated for cross-border passporting and local solicitation rules.
What is Inter's institutional risk classification, enforcement exposure, and score profile?
Inter carries a "risk level not supplied" classification in the source dataset (composite numeric scores are not supplied for this record). The record flags 0 regulatory warning or complaint counts and 1 licence record with elevated status flags (ICDX: no licence). Because these figures reflect imported source fields rather than primary audit findings, compliance teams should review primary enforcement bulletins directly.
What operational due diligence steps apply to Inter's platforms, entity structure, and complaints?
Before allocating capital or executing trades with Inter, institutional and retail allocators should: (1) confirm the domain (fxinterpan.com) against regulator-approved domains to guard against clone firms; (2) verify whether any of the 0 recorded warning/complaint entries or 0 user comments involve withdrawal restrictions or scope violations; and (3) confirm the dispute-resolution ombudsman tied to ICDX.
Related institutional research & regulatory analysis
Editorial briefings and compliance research from QuantCalc Tools relevant to Inter's supervisory scope.
Quantitative Pricing & Options Engines
NY Fed SOFR Index ACT/360 In-Arrears Compounding Engine: Cross-Margining & Capital Efficiency Optimization (4.4151% 90-Day Annualized Benchmark)
NY Fed SOFR Index ACT/360 In-Arrears Compounding Engine (SOFR-INDEX-ACT360) stands at 4.4151% (90-Day Annualized) (Source: NY Fed Reference Rates, 2026-10-20), governing inter-commodity correlation offsets and liquidity
Fixed Income Duration & Portfolio Risk
CME SPAN 2 Historical & Stress Value-at-Risk (VaR) Model: Cross-Margining & Capital Efficiency Optimization (6.26% Initial Margin / Notional Benchmark)
CME SPAN 2 Historical & Stress Value-at-Risk (VaR) Model (CME-SPAN2-VAR) stands at 6.26% (Initial Margin / Notional) (Source: CME Clearing, 2026-10-20), governing inter-commodity correlation offsets and liquidity add-on
Cleared Margin & VaR Models
Basel III FRTB 97.5% Expected Shortfall (ES) Tail Metric: Closed-Form Mathematical Specification & IEEE-754 Verification (97.5% Confidence Interval Benchmark)
Basel III FRTB 97.5% Expected Shortfall (ES) Tail Metric (FRTB-ES-975) stands at 97.5% (Confidence Interval) (Source: BIS Basel Committee MAR33, 2026-10-20), governing exact floating-point precision, day-count convention
Risk-Adjusted Performance Benchmarks
Basel III FRTB 97.5% Expected Shortfall (ES) Tail Metric: Worked $100M Institutional Portfolio Verification Example (97.5% Confidence Interval Benchmark)
Basel III FRTB 97.5% Expected Shortfall (ES) Tail Metric (FRTB-ES-975) stands at 97.5% (Confidence Interval) (Source: BIS Basel Committee MAR33, 2026-10-20), governing step-by-step cash flow, margin, and basis-point sens
